Optic neuritis following COVID-19 vaccination: Do autoimmune diseases play a role?

Vittorio PiraniPaolo PelliccioniMaria Jolanda CarpenèMichele NicolaiFederica BarbottiAlessandro FranceschiCesare Mariotti

Published in: European journal of ophthalmology (2022)

The reactogenicity of COVID-19 mRNA vaccine in individuals suffering from immune-mediated diseases is yet to be elucidated and it is being increasingly investigated. Our paper supports the hypothesis that patients who are already affected or predisposed to autoimmune or autoinflammatory disorders should be carefully evaluated for the benefits and risks of COVID-19 mRNA vaccination.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
respiratory syndrome coronavirus
multiple sclerosis
peritoneal dialysis
prognostic factors
optical coherence tomography
patient reported
optic nerve